Kitasamycin (CAS 69-23-8), C22H26F3N3OS, the formula weight is 437.52, and the form is white or light yellow crystalline powder, soluble in water, methanol or ethanol.
Kitasamycin is a multi-component macrolide antibiotic produced by Streptomyces. The free base is for oral use; the tartrate is for injection.

The global Kitasamycin (CAS 69-23-8) market is valued at xx million US$ in 2020 is expected to reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Kitasamycin (CAS 69-23-8) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Kitasamycin (CAS 69-23-8) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Kitasamycin (CAS 69-23-8) market is segmented into
95% Purity Type
97% Purity Type
98% Purity Type
Others

Segment by Application
Kitasamycin Dry Suspension
Kitasamycin Capsule
Kitasamycin Granule
Kitasamycin Tablets
Others

Global Kitasamycin (CAS 69-23-8) Market: Regional Analysis
The Kitasamycin (CAS 69-23-8) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Kitasamycin (CAS 69-23-8) market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Kitasamycin (CAS 69-23-8) Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Kitasamycin (CAS 69-23-8) market include:
Jiangmin Taihua Chemical
Shucan Shiye
Ruibang Laboratories
Topfond Pharma
Hebao Biotechnology
OK Chem
HPGC
Kangmu Pharm
PKU HealthCare